Recently, the Supreme Court has been at the center of attention once again, this time for a crucial decision regarding nationwide access to abortion. The focus of the upcoming appeal is on the approval process of the drug mifepristone, a medication commonly used for terminating pregnancies.
Oral arguments for this case are set to take place on Tuesday, with a ruling anticipated approximately three months later. This timing is significant as it coincides with the intense presidential election season, adding an extra layer of complexity to an already contentious issue.
